Oncotelic Therapeutics, Inc.
OTLC· OTC
OTLCOncotelic Therapeutics, Inc.
Filed Aug 12, 2011 · 10-Q · 43 days after period end · 0000950123-11-076704
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Net Income | -$2.93M | $2.54M |
| EPS Diluted | -$0.32 | $0.73 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oncotelic Therapeutics, Inc. · CIK 908259 · Engraved from SEC EDGAR
ended Jun 30, 2011 · filed Aug 12, 2011 · 43 d after period end
